Dr. Mauriņa Clinic is the first medical institution to utilise the next-generation Biolitec dual-wavelength laser system in the endovenous laser treatment. This state-of-the-art device represents the latest advancement currently available in endovenous laser ablation, enabling even greater procedural precision — the energy output and penetration depth of the laser fibre can be precisely calibrated to each individual venous segment, ensuring optimal energy delivery throughout the treated vessel.
Clinical Expertise at Dr. Mauriņa Clinic
In his presentation, Prof. Uldis Mauriņš reported that initial clinical outcomes confirm significant benefits — patients demonstrate accelerated postoperative recovery, while collateral tissue trauma during the procedure is further minimised. The presentation generated considerable interest among the congress audience, and following the session, Prof. Mauriņš engaged in extensive collegial discussion.
Dr. Romans Luņins presented Dr. Mauriņa Clinic's experience in implementing standardised endovenous laser ablation protocols. In his report, Dr. Luņins outlined how a unified surgical methodology ensures consistently high and reproducible treatment outcomes, regardless of the operating surgeon. The clinic employs an additional technological adjunct — an automated laser fibre withdrawal system — which maximises procedural precision and maintains a high standard of treatment quality across all cases.
"Years of intensive work have now come to fruition. The exceptional level of professional expertise within our clinical team has earned the trust not only of our patients, but also of colleagues worldwide — including Biolitec, the global leader in venous laser technology. The company has chosen to collaborate with our experienced team of physicians to jointly develop a treatment protocol that will in future be adopted by every medical institution working with their latest laser platform."
— Prof. Uldis Mauriņš
